Safety and early efficacy assessment of liposomal daunorubicin (DaunoXome) in adults with refractory or relapsed acute myeloblastic leukaemia: a phase I-II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples